BioSpace News Archive

A new study commissioned by The Leukemia & Lymphoma Society finds that patients can still face steep out-of-pocket costs three years after initial diagnosis; consumers should closely consider their coverage options during open enrollment

Avantor, Inc. (NYSE: AVTR), announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on November 15, 2019 to holders of record on November 1, 2019.

Nearly $500,000 in funding in Four Key Areas

Data Being Presented at CHEST Annual Meeting 2019

The webcast will be archived for approximately 30 days following the event.

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced it will present results from its pivotal Phase 3 CONFIRM study in a late-breaker session on Monday, Nov. 11 at 3:30 pm ET during The Liver Meeting® 2019, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston.

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced that Chief Executive Officer Patrick Jordan will present at the 2019 BIO Investor Forum being held October 22-23 at the Westin St. Francis in San Francisco, Calif.

Shenango is a continuing care retirement community/life plan community located in New Wilmington, PA.

The findings run counter to recommendations from professional societies and is based on results from a randomized clinical trial that included 1,500 survivors of acute coronary syndromes.

Grants Will Streamline Access to Benefits for Five Million People Living in Poverty by 2025